Behavioral, electroencephalographic, and evoked potential studies, as well as experiments utilizing the direct intracerebral injection of benzodiazepines (BZs), have implicated the amygdala, particularly its basolateral nuclear division, as an important locus of the therapeutic actions of these drugs. BZ receptor localization within the amygdala could further define which amygdaloid nuclei are important for BZ action and suggest neuroanatomical pathways especially sensitive to these drugs. Using a quantitative light microscopic autoradiographic technique, this study has localized type 1 and type 2 BZ receptors within the amygdaloid nuclear complex of the rat. BZ receptors were labeled with [3H]flunitrazepam, and type 1 BZ receptor binding was preferentially displaced by CL218872 in 8pm coronal sections of rat brain. Autoradiograms were generated by the apposition of emulsion-coated coverslips and quantified by standardized procedures. Ten amygdaloid nuclei were examined at nine levels over the rostrocaudal extent of the amygdala. Total BZ receptor density was highest in the basolateral nuclear complex, and the majority of these receptors were of the type 2 subclass. Type 1 receptors were concentrated in the anterior aspects of the amygdala, particularly the anterior cortical nucleus. These results are consistent with an important role for the basolateral amygdala in anxiogenesis and seizure induction. Furthermore, a larger circuit which includes the amygdala, ventromedial hypothalamus, mammillary body, anterior thalamus, and frontal cortex could be involved in the anxiolytic actions of the BZ drugs.
fearful, behavior. In a variety of mammalian species, stimulation of the basolateral nuclear division of the amygdala evokes fearful or defensive behavior (Ursin and Kaada, 1960; Ursin, 1971) , whereas lesions of this region result in a reduction in such behavior (Pellegrino, 1968; Swartzwelder, 1980) . In humans, electrical stimulation of the amygdaloid complex produced a subjective sensation of fear or anxiety, as well as autonomic responses characteristic of fear, such as increases in heart rate and blood pressure, and pupillary dilation (Chapman et al., 1954) . A role for the amygdala in the anticonvulsant actions of BZs is suggested by the vulnerability of this structure to the induction of "kindled" seizures and by the ability of intra-amygdaloid kainic acid to elicit a fatal myoclonic seizure pattern in rats similar to status epilepticus (Ben-Ari et al., 1979) . Studies involving the direct application of BZs to the amygdala have elicited the anxiolytic and anticonvulsant effects of these drugs. For example, direct application of diazepam to the anterior amygdala of cats resulted in EEG alterations as well as attenuation of the carbachol-induced "rage" reaction, a measure of emotionality (Nagy and Desci, 1973) , while in rabbits, direct application of diazepam to the anterior amygdala strongly elevated the pentylenetetrazol-induced seizure threshold (Nagy and Desci, 1979) . In studies utilizing the conflict paradigm in rats as a measure of anxiolytic potency, direct bilateral injection of diazepam into the amygdala resulted in increases in lever pressing during shock periods (Nagy et al., 1979) . Several other recent studies have also reported that direct application of midazolam into the lateral and basolateral (Scheel-Kruger and Petersen, 1982) or central (Shipata et al., 1982) amygdaloid nuclei increased punished responding in a conflict paradigm.
Thus, it would be reasonable to hypothesize that the amygdala would contain significant levels of receptors for BZs, particularly in its more anterior aspects and in the lateral and basolateral nuclei. Autoradiographic evidence confirmed the existence of BZ receptors in the lateral nucleus at a medial level of the amygdala (Young and Kuhar, 1980) . The discovery of the triazolopyridazine (TPZ) drugs, typified by CL218872 (3-methyl-6-[3-(trifluoromethyl)phenyl]-1,2,4-triazolopyridazine), allowed the division of BZ receptors into type 1 (high affinity for TPZs) and type 2 (low affinity for TPZs) subclasses (Lippa et al., 1979a, b; Klepner et al., 1979; Squires et al., 1979) . Because CL218,872 is highly effective in increasing punished behavior and protects against pentylenetetrazol-induced seizures, but is nonsedating, it was originally proposed that type 1 receptors may be of greater importance in mediating the therapeutic effects of BZs (Lippa et al., 1979a, b; Squires et al., 1979) . Hence, the amygdala might be expected to be a region enriched in type 1 receptors. This can be examined using a modification of the light microscopic autoradiographic technique for localizing BZ receptors which involves the use of CL218,872 to selectively block binding to type 1 receptors (Young et al., 1981) .
The current study utilizes this modified BZ receptor localization method to quantitatively determine both the total BZ receptor density and the type 1:type 2 receptor ratio in the nuclear subdivisions of the rat amygdala at several levels encompassing its rostrocaudal extent.
Materials
and Methods BZ receptors were labeled in 8-pm coronal sections of rat brain according to previously established procedures (Young et al., 1981 pH 7.4 . The sections were then washed for 2 min in the same buffer, briefly rinsed in distilled water, and dried under a stream of cool, dry air. Blanks were generated by the inclusion of 1 PM clonazepam in the incubation medium. Following incubation and drying, autoradiograms were generated by the apposition of emulsion-coated coverslips for a 2-week exposure period. Grain densities were determined using a Zeiss Universal microscope equipped with an eyepiece overladen with a calibrated grid. Molar densities were obtained from grain counts by comparison with a standard curve. The standards consisted of sections of brain paste containing known amounts of radioactivity. Slides containing eight such sections with increasing amounts of radioactivity were also apposed to emulsion-coated coverslips and co-exposed with the autoradiograms (Unnerstall et al., 1981) .
Type 1 and type 2 BZ receptors were differentiated by the addition of 200 nM CL218,872 to the incubation medium, as previously described (Young et al., 1981) . Assuming a KD value of 1 nM for [3H]FLU at both type 1 and type 2 sites (Young et al., 1981) , and Ki values of 10 nM and 1000 nM for CL218,872 at types 1 and 2 sites (Niehoff and Kuhar, 1982; Yamamura et al., 1980) By incubating serial sections in the presence and absence of 200 nM CL218,872, values can be obtained for total and displaceable binding in any brain region of interest and inserted into the simultaneous equations to obtain the density of type 1 and type 2 receptors.
Both total BZ receptor density and type l/type 2 densities were determined in 10 amygdaloid nuclei, as well as the anterior amygdaloid area, from a level just posterior to the anterior commissure (A6670; Konig and Klippel, 1963) to the most caudal aspect of the amygdala (A2790; Konig and Klippel, 1963) . Anatomical differentiation of the various nuclei, as well as terminology, are taken from Krettek and Price (1978) .
Results
As previously demonstrated elsewhere (Unnerstall et al., 1981) , grain density in the autoradiographic standards increased in a nonlinear fashion with increasing radioactivity (data not shown). Logarithmic transformation of the data yielded a linear function for the standard curve with a slope of 0.482. Grain densities were converted to dpm/mg of tissue by use of this curve, and molar densities were obtained by use of these values and the specific activity of the ligand. Grain densities varied by less than 10% in identical standard sections apposed to three separate coverslips.
In total, data from nine levels of the amygdaloid nuclear complex are presented. (Konig and Klippel, 1963) .
In general, the density of BZ receptors ranged from moderate to very dense throughout the amygdala, as well as in adjacent olfactory structures, i.e., the periamygdaloid and pyriform cortices and the nucleus of the lateral olfactory tract (Figs. 1 to 8) . The lateral nucleus, the A4620 A4360 A4110 A2790
Figures 1 to 5.3 Schematic representation of total BZ receptor density and type 1 receptor density in the rat amygdala. The upper drawing of each group of three (a) defines the amygdaloid nuclei and related structures visible at that level. The second drawing (b) portrays the total specific'BZ receptor density, and the third (c) depicts the percentage of total specific binding attributable to type 1 receptors. Values for total specific binding and CL218,872-displaceable binding were obtained by grain counting in autoradiograms generated as described under "Materials and Methods." Grain count values were converted to molar densities by use of the standard curve. Blank values were obtained in the presence of 1 pM clonazepam; specific binding constituted at least 98.7% of the total binding. Line drawings are modified from Konig and Klippel (1963) with terminology revised to reflect the nuclear divisions of Krettek and Price (1978 3 The abbreviations used in the figures are: AA, anterior amygdaloid posterior division of the lateral amygdaloid nucleus; am, medial amygarea; abl, basolateral amygdaloid nucleus; abl., anterior division of the daloid nucleus; amd, posteriodorsal medial amygdaloid nucleus; CAIR, basolateral amygdaloid nucleus; abl,, posterior division of the basolainternal capsule; CE, dorsal division of the lateral entorhinal area; CL, teral amygdaloid nucleus; abm, basomedial amygdaloid nucleus; a~, claustrum; cp, caudate nucleus; ec, dorsal division of the lateral entorcentral amygdaloid nucleus; ace, cortical amygdaloid nucleus; ace., hinal area; hi, hippocampus; GP, globus pallidus; ol, nucleus of lateral anterior cortical amygdaloid nucleus; ace,, posterior cortical amygdaloid olfactory tract; pc, posterior division of the prepiriform cortex; poma, nucleus; ala, anterior division of the lateral amygdaloid nucleus; alp, preoptic nucleus; TO, optic tract.
Figures 6 to 8. Darkfield photomicrographs at three representative levels of BZ receptors in the rat amygdala. In these photos, the tissue is not visible and the relative brightness is associated with grain densities. Thus, the brightest areas have the highest density of BZ binding sites. Figure 6 shows A5780, Figure 7 shows A4620, and Benzodiazepine Receptors in Rat Amygdala 2095
anterior and posterior cortical nuclei, and the more cauda1 aspect of the posterior basolateral nucleus contained the highest total densities of BZ receptors, whereas the central nucleus consistently displayed the lowest density of receptors. The majority of the receptors were of the type 2 subclass, although some nuclei contained a sizeable proportion of type 1 receptors, particularly in the more anterior portions of the amygdala. The analysis of total and subtype receptor densities in individual nuclei revealed localization patterns consistent with cytoarchitectonic divisions of the nuclei and, in some cases, pronounced rostral-caudal gradients. The anterior and posterior divisions of the lateral nucleus in the rat can be differentiated on the basis of cell size, with tbe anterior division composed of smaller, more tightly packed cells (Krettek and Price, 1978) . Both divisions contained a high density of BZ receptors (Figs. 1 to 8) , with the anterior division being slightly enriched (Figs. 1 to 3) . The posterior division contained slightly higher levels at its more caudal aspect (A4380 and beyond, Figs. 2 to 4, 6, and 7). The most striking difference between the two divisions was the high relative density of type 1 receptors in the anterior division. The central nucleus contained the lowest density of BZ receptors, and the majority of these receptors were of the type 2 subclass. No attempt was made to distinguish receptor densities in the lateral versus the medial subdivisions (Krettek and Price, 1978) of this nucleus. The basomedial nucleus also contained relatively low receptor densities, except in its most caudal aspects. Overall, it also contained primarily type 2 receptors (Figs.  1 to 7) .
Like the anterior and posterior subdivisions of the lateral nucleus, the basolateral nucleus can be subdivided into a magnocellular anterior division and a parvocellular posterior part (Krettek and Price, 1978) . The anterior division contained a moderately high density of total BZ receptors about equally divided between the two subtypes (Fig. 2) . The posterior portion contains a gradient in the total receptor density which rises to a peak at A4110 (Figs. 3 and 4) and then declines sharply. A similar, steeper gradient in the proportion of type 1 receptors paralleled the total density distribution (Figs. 3 and 4) .
The medial nucleus can be separated into an anterior division and a compact, small-celled posterodorsal division (Krettek and Price, 1978) . The total density of BZ receptors in the cellular layer (II) remained relatively constant over the extent of both nuclei until the most posterior levels, where it declines sharply (Figs. 2 to 7) . Within the anterior portion, the density of Type 1 receptors declines rostrocaudally from moderately high to nonexistent, while a peak of type 1 receptors marks the anterior posterodorsal border of the medial nucleus (Figs.  2 to 7) .
The cellular layer (II) of the anterior cortical nucleus (Krettek and Price, 1978) contains a high density of BZ receptors. The anterior aspects of this nucleus are unique in that they contain the highest density of type 1 receptors (Figs. 1,2 , and 6) in the amygdala. The level of type 1 receptors declines gradually, rostrocaudally (Figs. 1 to  3) .
The posterior cortical nucleus is highly enriched in BZ receptors (Figs. 4, 5, and 8 ). This nucleus contained moderately high levels of type 1 receptors (Figs. 4,5, and  8) .
The anterior amygdaloid area contains low levels of type 2 BZ receptors (Fig. 1) . Table I summarizes the distribution of total BZ receptor density in the entire emygdaloid nuclear complex, as well as in its basolateral and corticomedial nuclear subdivisions at all levels examined in this study. It is clear from this table that the basolateral subdivision contains far more BZ receptors than does the corticomedial division at all levels. Table  II provides a similar summary of the type 1 receptor subtype distribution and reveals an overall enrichment of this subtype in the more anterior aspects of the amygdala. The corticomedial subdivision also contains an additional peak in type 1 receptor density in its more caudal aspects, coinciding with the appearance of the posterior cortical nucleus and posteriodorsal medial nucleus, in contrast with a gradual decline in type 1 density rostrocaudally in the basolateral complex.
Discussion
The results obtained in this study demonstrate a high density of BZ receptors in the rat amygdala and also identify the majority of these receptors as being of the type 2 subclass. Total BZ receptor density appeared to be much higher in the phylogenetically recent basolateral (basal and lateral nuclei) nuclear subgroup as opposed to the more primitive corticomedial (cortical, medial, and central nuclei) subgroup at most levels examined.4 Type 1 receptors appeared to be restricted to a few nuclei and to follow a pronounced rostrocaudal decline within those nuclei. In the rest of the amygdala, type 1 receptors comprised at best 30 to 40% of the overall receptor density and were undetectable at some levels in some nuclei. The highest levels of type 1 receptors were located in the anterior cortical nucleus and anterior lateral nucleus, while the highest levels of type 2 receptors were found in the posterior lateral nucleus, the basomedial nucleus, and the central nucleus. Thus, type 1 receptors appear to be concentrated in the more anterior portions of the amygdala.
Our results confirm our previous autoradiographic studies identifying the amygdala as a region of high BZ receptor density (Young and Kuhar, 1980) . The anatomical distribution of total BZ receptor density in the various amygdaloid nuclei would tend to suggest that the basolateral nuclear subgroup might be the more important in mediating the actions of BZs. The behavioral evidence implicating the lateral amygdala as a site important in fearful responses and fear-inducing operant paradigms (Ursin and Kaada, 1960; Pellegrino, 1968; Ursin, 1971; Swartzwelder, 1981) , as well as studies which have elicited the anxiolytic action of BZs by direct application (Scheel-Kruger and Petersen, 1982) to the lateral or basolateral nuclei support this possibility. Surprisingly, these nuclei contain relatively few type 1 receptors at most levels examined. Thus, the idea that type 1 receptors are primarily associated with the therapeutic actions of BZs, whereas type 2 receptors are associated with unwanted side effects (Lippa et al., 1979a, b) seems less plausible, although one cannot rule out that the low levels of type 1 receptors are important.
High levels of BZ receptors are found in other limbic and cortical regions that receive projections from the amygdala. These include the hippocampus, subiculum, ventromedial hypothalmus, and lamina IV of the cerebral cortex (Young and Kuhar, 1981) , suggesting that certain neuroanatomical pathways will be strongly influenced by BZ drugs. The activation of such pathways may be related to anxiogenic and fearful responses or a basis of seizure induction. For example, amygdaloid-kindled seizures have been shown to result in alterations in hippocampal BZ receptors (McNamara et al., 1980) , and local destruction of amygdaloid neurons by the application of a kainic acid has been shown to result in hippocampal degeneration and a seizure pattern resembling status epilepticus (Ben-Ari et al., 1979) . As the lateral and basolateral amygdaloid nuclei are connected to the hippocampus in the rat via the lateral entorhinal area and subiculum, respectively (Krettek and Price, 1977, 1978) , a pathway comprised of amygdala-entorhinal cortex/ subiculum-hippocampus may be the anatomical basis of these observations. Similarly, a recent study identified the mammillary body as another site at which direct application of BZs could elicit potent anticonflict activity (Kataoka et al., 1982) and outlined a pathway to mediate this activity composed of mammillary body + anterior thalamus (Cruce, 1975; 1977 ) --, frontal cortex (Domesick, 1972 Divac et al., 1978) . As the mamillary body receives an input from the ventromedial hypothalamus, which in turn receives input from the basomedial and medial nuclei of the amygdala (Krettek and Price, 1978), a possible extension of this pathway would include: lateral amygdaloid nucleus-basomedial amygdaloid nucleus (Krettek and Price, 1978) ventromedial hypothalamus (Krettek and Price, 1978)-mammillary body-anterior thalamus-frontal cortex. Direct connections between the basolateral and lateral nuclei and frontal cortex (Krettek and Price, 1978) may also be important in the anticonflict effects of BZs. Lippa et al. (1979a, b) have shown that the frontal cortex was important in the disinhibition of punished behavior by BZs. These proposed pathways suggest alternative sites for future direct application and lesion studies to further localize the therapeutic actions of BZs. A preliminary report of these data has appeared (Niehoff and Kuhar, 1982) .
